An anticoagulant/procoagulant self-converting and bleeding site targeting systemic nanotherapy for rapid controlling of non-compressible bleeding without risk of thrombosis

CONCLUSIONS: PSNs is expected to be a low-cost, safe, efficient, clinically translatable first-aid hemostat for first-aid scenarios.PMID:36871669 | DOI:10.1016/j.jtha.2023.02.020

Source: Thrombosis and Haemostasis - March 5, 2023 Category: Hematology Authors: Yuchuan Yuan Jiaxing Liu Hongli Duan Chengyuan Zhang Wenxing Wu Qin Qin Jie Lou Qing Zhang Qin Wang Xiaohui Li Xing Zhou Source Type: research